Esmeralda C. Teo

711 total citations · 1 hit paper
8 papers, 515 citations indexed

About

Esmeralda C. Teo is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Esmeralda C. Teo has authored 8 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Esmeralda C. Teo's work include Acute Myeloid Leukemia Research (2 papers), Liver Disease and Transplantation (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Esmeralda C. Teo is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Liver Disease and Transplantation (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Esmeralda C. Teo collaborates with scholars based in Singapore, United States and United Kingdom. Esmeralda C. Teo's co-authors include Seng Gee Lim, Chee‐Kiat Tan, Chong–Gee Teo, Pauline Aw, Michael A. Purdy, Yuan Zhu, Boon Huan Tan, Martin L. Hibberd, Guan Huei Lee and Aileen Wee and has published in prestigious journals such as Gastroenterology, International Journal of Hydrogen Energy and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Esmeralda C. Teo

8 papers receiving 505 citations

Hit Papers

Chronic Infection With Camelid Hepatitis E Virus in a Liv... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esmeralda C. Teo Singapore 6 417 332 53 52 29 8 515
Jian Han China 10 343 0.8× 272 0.8× 72 1.4× 82 1.6× 11 0.4× 24 427
Pauline Trémeaux France 11 149 0.4× 219 0.7× 10 0.2× 89 1.7× 37 1.3× 25 329
Ila Nimgaonkar United States 8 578 1.4× 324 1.0× 26 0.5× 139 2.7× 107 3.7× 10 684
Martina Sombetzki Germany 11 134 0.3× 56 0.2× 51 1.0× 153 2.9× 55 1.9× 33 476
Junhui Xiong China 9 229 0.5× 158 0.5× 24 0.5× 81 1.6× 44 1.5× 20 325
Ayşın Zeytinoğlu Türkiye 10 99 0.2× 66 0.2× 19 0.4× 243 4.7× 68 2.3× 48 398
Auristela Valdés Spain 8 411 1.0× 112 0.3× 26 0.5× 331 6.4× 15 0.5× 16 444
Reshu Agarwal India 9 26 0.1× 186 0.6× 13 0.2× 152 2.9× 28 1.0× 43 291
Bùi Tiến Sỹ Vietnam 11 229 0.5× 88 0.3× 7 0.1× 199 3.8× 18 0.6× 26 313
Kathleen A. Linder United States 11 24 0.1× 199 0.6× 26 0.5× 257 4.9× 19 0.7× 31 336

Countries citing papers authored by Esmeralda C. Teo

Since Specialization
Citations

This map shows the geographic impact of Esmeralda C. Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmeralda C. Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmeralda C. Teo more than expected).

Fields of papers citing papers by Esmeralda C. Teo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmeralda C. Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmeralda C. Teo. The network helps show where Esmeralda C. Teo may publish in the future.

Co-authorship network of co-authors of Esmeralda C. Teo

This figure shows the co-authorship network connecting the top 25 collaborators of Esmeralda C. Teo. A scholar is included among the top collaborators of Esmeralda C. Teo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esmeralda C. Teo. Esmeralda C. Teo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Teo, Esmeralda C., Boon Huan Tan, Michael A. Purdy, et al.. (2017). Hepatitis E in Singapore: A Case-Series and Viral Phylodynamics Study. American Journal of Tropical Medicine and Hygiene. 96(4). 922–928. 2 indexed citations
2.
Ji, Jie, Benigno C. Valdez, Yang Li, et al.. (2016). Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study. Experimental Hematology. 44(6). 458–465. 5 indexed citations
3.
Valdez, Benigno C., Jonathan E. Brammer, Yang Li, et al.. (2016). Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells. Leukemia Research. 47. 100–108. 7 indexed citations
4.
Teo, Esmeralda C., Benigno C. Valdez, Jie Ji, et al.. (2016). Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells. Leukemia & lymphoma. 57(11). 2644–2652. 5 indexed citations
5.
Teo, Esmeralda C., et al.. (2015). A review of monoclonal antibody therapies in lymphoma. Critical Reviews in Oncology/Hematology. 97. 72–84. 29 indexed citations
6.
Lee, Guan Huei, Boon Huan Tan, Esmeralda C. Teo, et al.. (2015). Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. Gastroenterology. 150(2). 355–357.e3. 428 indexed citations breakdown →
7.
Teo, Esmeralda C., et al.. (2007). Guillain--Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection.. PubMed. 12(3). 62–3. 15 indexed citations
8.
Teo, Esmeralda C., et al.. (2004). A critical pathway energy efficiency analysis of the thermochemical UT-3 cycle. International Journal of Hydrogen Energy. 30(5). 559–564. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026